ARID4B and metabolic dysfunction-associated steatotic liver disease: BCAA and/or BCKA levels are elevated in diseases including heart failure (HF)10–13, type 2 diabetes mellitus (T2DM)14,15, non-alcoholic fatty liver disease (NAFLD)16, and obesity17–19.